Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Venlafaxine"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringVenlafaxine
brandStringEffexor XR, Effexor IR (discontinued in US, generic widely available)
structureFile
classesList of String, delimiter: ,[[:Category:SNRIs|Serotonin-norepinephrine reuptake inhibitor (SNRI)]] [[:Category:Antidepressants|Antidepressant]] [[:Category:Anxiolytics|Anxiolytic]]
mechanismString
usesString'"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"'
starting_doseStringXR 37.5 mg PO once daily for 4-7 days, then 75 mg/day; titrate by 75 mg every ≥4 days to clinical effect. IR 25-37.5 mg BID-TID
preparationsStringIR tablets 25, 37.5, 50, 75, 100 mg; XR capsules 37.5, 75, 150, 225 mg
fda_maxString225 mg/day outpatient (XR); 375 mg/day inpatient (IR divided TID); 75 mg/day in moderate hepatic impairment
pill_idText
routesList of String, delimiter: ,Oral
onsetStringAntidepressant effect over 1-2 weeks; anxiolytic effect over 4-6 weeks
durationString24 hours (XR); 12 hours (IR)
halflifeStringVenlafaxine 5 hours; desvenlafaxine active metabolite 11 hours'"`UNIQ--ref-00000026-QINU`"'
bioavailabilityString~45%'"`UNIQ--ref-00000027-QINU`"'
pregnancyStringObservational signal for neonatal adaptation syndrome with late-pregnancy exposure; weigh against the risks of untreated maternal depression.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US. Carries the antidepressant '''Boxed Warning''' for suicidality in children, adolescents, and young adults'"`UNIQ--ref-00000028-QINU`"'